Fierce Healthcare February 12, 2024
Paige Minemyer

Private equity firms have seen plenty of potential in the rapidly growing Medicare Advantage space, but deal volumes are slowing, according to a new report.

Analysts at the Private Equity Stakeholder Project dug into deal activity in MA between 2016 and 2023. The report (PDF) found that deals peaked in 2021 and have slowed in the years since as tighter regulations and nationwide inflation impact the sector.

The report found that there were 80 PE-backed deals—including leveraged buyouts, add-on acquisitions and growth investments—from 2016 to 2023. Of those, more than half (56.3%) were add-on acquisitions for platform companies.

The two busiest years for dealmaking were 2019 and 2021, with a likely pandemic-driven lull in between, according to the report. However,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Investments, Medicare Advantage, Mergers & Acquisitions / JV, Survey / Study, Trends
Growth in Medicare Advantage Raises Concerns
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
A Stronger Medicare Program—Now And Into The Future
Medicare Privatization Is Breaking the Bank
Executive Outlook 2025: While MA ‘Tightens the Screws’ on Nursing Homes, Sector Focuses on Reform, Workforce Solutions, I-SNPs

Share This Article